Resumen

NICHOLSON, S A  y  PEPPER, M S. CRISPR-Cas: Revolutionising genome engineering. SAMJ, S. Afr. med. j. [online]. 2016, vol.106, n.9, pp.870-871. ISSN 2078-5135.  http://dx.doi.org/10.7196/samj.2016.v106i9.11061.

The ability to permanently alter or repair the human genome has been the subject of a number of science fiction films, but with the recent advent of several customisable sequence-specific endonuclease technologies, genome engineering looks set to become a clinical reality in the near future. This article discusses recent advancements in the technology called 'clustered regularly interspaced palindromic repeat (CRISPR)-associated genes' (CRISPR-Cas), the potential of CRISPR-Cas to revolutionise molecular medicine, and the ethical and regulatory hurdles facing its application.

        · texto en Inglés     · Inglés ( pdf )